Chemodex

Phloretin

CHF 52.00
In stock
CDX-P0487-M100100 mgCHF 52.00
CDX-P0487-M250250 mgCHF 103.00
More Information
Product Details
Synonyms 3-(4-Hydroxyphenyl)-1-(2,4,6-trihydroxyphenyl)-1-propanone
Product Type Chemical
Properties
Formula C15H14O5
MW 274.27
CAS 60-82-2
Source/Host Chemicals Plant
Purity Chemicals ≥98% (HPLC)
Appearance White to off-white powder.
Solubility Soluble in DMSO, ethanol or methanol. Insoluble in water.
Identity Determined by 1H-NMR.
Declaration Manufactured by Chemodex.
Other Product Data

Click here for Original Manufacturer Product Datasheet
Our product description may differ slightly from the original manufacturers product datasheet.

InChi Key VGEREEWJJVICBM-UHFFFAOYSA-N
Smiles Oc1ccc(CCC(=O)c2c(O)cc(O)cc2O)cc1
Shipping and Handling
Shipping AMBIENT
Short Term Storage +20°C
Long Term Storage +4°C
Handling Advice Protect from light and moisture.
Use/Stability Stable for at least 2 years after receipt when stored at +4°C.
Documents
MSDS Inquire
Product Specification Sheet
Datasheet Download PDF
Description

Phloretin is a natural dihydrochalcone, originally identified from the apple tree, and is a metabolite of phlorizin. It has numerous pharmacological effects, including anti-inflammatory, antidiabetic, anticancer, antimicrobial, hepatoprotective, neuroprotective and cytoprotective properties. Phloretin is a potent antioxidant, scavenging peroxynitrite (ONOO-) and/or suppressing lipid peroxidation, which contributes to the many biological properties. Phloretin has anti-aging and depigmenting effects, making it also attractive for dermatological research and application. Phloretin attacks a number of molecular targets, modulating different intracellular signaling pathways, including NF-κB, MAPK, Nrf2, and AMPK. It can modulate Ca2+ channels, PKC, GLUTs, SGLTs and other targets. The anticancer potential is based on antiproliferative, proapoptotic, antimetastatic, and antiangiogenic activities.

Product References

(1) M.R. de Oliveira; Biofactors 42, 13 (2016) (Review) | (2) B.Y. Choi; Molecules 24, 278 (2019) (Review) | (3) T.P.A. Casarini, et al.; Eur. J. Pharmacol. 889, 173593 (2020) (Review) | (4) K.T. Nakhate, et al.; Nutrients 14, 3638 (2022) (Review) | (5) H.S. Tuli, et al.; Molecules 27, 8819 (2022) (Review) | (6) S. Habtemariam;, Biomedicines 11, 143 (2023) (Review)

© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.